About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 478 record(s)
Req # A-2022-000092
Adverse Drug Reaction (ADR) for Finasteride. Report number: 000938293. ADR for Nitrofurantoin. Report number: 000959174.Organization: Health Canada
May 2022
Req # A-2022-000102
Adverse Drug Reaction (ADR) for CANCIDAS. Report number: E2B_02706392.Organization: Health Canada
May 2022
Req # A-2022-000111
Adverse Drug Reaction (ADR). Report number: 000976770.Organization: Health Canada
May 2022
Req # A-2022-000161
Adverse Drug Reaction (ADR) for Ramipril. Report number: 000943180. ADR for Citalopram. Report number: 000950747. ADR for Telmisartan. Report number: 000942789.Organization: Health Canada
May 2022
Req # A-2022-000204
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-104169-513.Organization: Health Canada
May 2022
Req # A-2022-000207
Adverse Drug Reactions (ADRs). Report numbers: 000982819, 000983099, 000983100, 000983750, 000985037, 000985192.Organization: Health Canada
May 2022
Req # A-2022-000229
Adverse Drug Reaction (ADR) for VEKLURY. Report number: 000976680.Organization: Health Canada
May 2022
Req # A-2017-000390
All information notes (or briefing notes) and emails to the Minister and/or their office and to Deputy Ministers and Assistant Deputy Ministers on Canada’s Food Guide and the Food Policy for Canada, for the periods from January 1, 2004 to December 31, 2007, and January 1, 2013 to August 29, 2017.Organization: Health Canada
May 2021
Req # A-2017-001026
All mentions of "juice", "fruit juice", "fruit drinks," "Canadian Beverage Association," "CBA," in e-mail, records or correspondence related to the revision process of Canada's Food Guide from January 1, 2013 to November 1, 2017.Organization: Health Canada
May 2021
Req # A-2018-001653
With regard to the Draft Screening Assessment - Talc (available at https://www.canada.ca/content/dam/eccc/documents/pdf/pded/talc/Draft-screening-assessment-talc.pdf and attached to this request). (i) The comments on the “technical portions” made by Ms. Lopez, Ms. Super, and Ms. Jeney of Tetra Tech (as referred to on p. 2 of the Draft Screening Assessment - Talc). All records related to the comments referred to in (i).Organization: Health Canada
May 2021